Country Experiences: Eastern Europe / Czech Republic

European Meeting on HIV & Hepatitis 2022

Country Experiences: Western Europe / France

European Meeting on HIV & Hepatitis 2022

Impact of Covid Pandemic on HIV Epidemiology and Cascade of Care in Europe

European Meeting on HIV & Hepatitis 2022

Special Lecture: Current Outbreaks of Concern

European Meeting on HIV & Hepatitis 2022

Early Clinical Phase - Antiviral Drugs

European Meeting on HIV & Hepatitis 2022

Early Clinical Phase - Monoclonal Antibodies

European Meeting on HIV & Hepatitis 2022

Impact of Variants on Clinical Presentation and Outcome in Severe COVID Disease

European Meeting on HIV & Hepatitis 2022

Dimitrios Paraskevis | European Meeting on HIV & Hepatitis 2022, Day 1

European Meeting on HIV & Hepatitis 2022

Seroprevalence of SARS-CoV-2 infection and evolution of humoral immune response in PLWHIV in the Ile-de-France area

European Meeting on HIV & Hepatitis 2022

Development of Interferon-Gamma Release Assays for Diagnosing Latent Talaromycosis - Helen Xu

APACC 2022

Intensified Screening for Mycobacterial Infections Using Gen-xpert Directly in Blood and Mycobacterial Culture in Hospitalized Patients with Advanced HIV Diseases in Vietnam - Dieu Nguyen

APACC 2022

Effects of HIV-Integrated TB interventions on Care Continuum Outcomes for Active TB: A Systematic Review and Meta-Analysis - Gifty Marley

APACC 2022

High Sexually Transmitted Infection Prevalence / Incidence Among New, Current, and Non-Users of Pre-Exposure Prophylaxis and HIV-Positive Men Who Have Sex with Men and Transgender Women Attending Key Population-Led Clinics in Thai - Narukjaporn Thammajaru

APACC 2022

Impact of COVID-19 Lockdown on Testing for and Diagnoses of Sexually Transmitted Infections in Bangkok, Thailand - Napon Pungpapong

APACC 2022

Weight Change when Discontinuing Integrase Strand Transfer Inhibitors in People Living with HIV - Warittha Tieosapjaroen

APACC 2022

Asian Phase 3/3b Experience With Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes Through Week 96 - Shinichi Oka

APACC 2022

Higher CD4/CD8 Ratio Recovery Observed Among People Living with HIV Started with Integrase Strand Transfer Inhibitors - Win Min Han

APACC 2022

Real-World Efficacy of INSTI-Containing Antiretroviral Therapy in Treatment-Naïve People Living with HIV - Yayoi Nakamura

APACC 2022

Rapid Tenofovir-Lamivudine-Dolutegravir Transition in Papua New Guinea: A Virtual Approach to Antiretroviral Prescriber Refresher Trainings During a Global Pandemic - Poruan Temu

APACC 2022

Implementation Strategies to Enable Initiation of Same-day Antiretroviral Therapy by Lay Providers in Two Community Based Organizations in Bangkok, Thailand - Rena Janamnuaysook

APACC 2022

Differences in Methamphetamine Use Characteristics Among People with Opioid Use Disorders Under Methadone Treatment in The Two Big Cities in Vietnam: Preliminary Analysis from the STAR-OM Study - Nguyen Thu Trang

APACC 2022

Homoprejudiced Violence Experience, Depression, and High-Risk Sex Behavior Among MSM in China: A Mediation Analysis - Xumeng Yan

APACC 2022

Recreational Drugs are Associated with Viral Load Blips and Lower Adherence in a Prospective Cohort of Thai People with Acute HIV Infection - Camilla Muccini

APACC 2022

Linking Female Entertainment Workers in Cambodia to HIV, Sexual and Reproductive Health, and Gender-Based Violence Services: The Mobile Link Randomized Controlled Trial - Siyan Yi

APACC 2022